Navigation Links
Swype Cold & Flu Shield Significantly Reduces Occurrence of Colds in Clinical Study
Date:9/27/2011

PONTE VEDRA BEACH, Fla., Sept. 27, 2011 /PRNewswire/ -- Nuance Health today announced the results of an eight-week clinical study that was conducted on their innovative product, Swype Cold & Flu Shield, during the 2010-11 cold and flu season.  

The clinical study, conducted on 103 volunteers who identified themselves as typically susceptible to colds, evaluated the effectiveness, tolerability, and willingness of participants to use a nasal gel to prevent illness.  In previous testing performed by an independent microbiology laboratory, the active ingredients in Swype have been shown to kill over 99.9% of all 25 cold and flu viruses tested including 15 serotypes of rhinovirus and swine influenza (H1N1).  In the study, participants were instructed to use Swype three times daily for eight weeks during the cold and flu season.  The volunteers reported actual use of the product and cold symptoms via weekly email surveys.

The results of the clinical study were outstanding.  Over 83% of volunteers used Swype two or three times per day during the study, an excellent compliance rate for a prophylactic product (fewer people wash their hands after using the bathroom).  In a typical cold and flu season, about 45% of participants would have experienced moderate or stronger cold symptoms during an eight-week period, but only 2% of Swype users reported more than mild cold symptoms.  Overall, users of Swype experienced about 70% fewer colds than anticipated, an unprecedented result for a cold prevention product.

Volunteers in the study offered unprompted praise for Swype Cold & Flu Shield: "I love Swype and tell many about your product," "Overall the product is invisible, light, and easy to use," "Everyone around me is sick, but not me," and "I actually had a cold when I started using Swype and within one day it was gone" are examples of comments posted by Swype users.

"I am very excited about the results of this study," said Dr. Kent New, the creator of Swype and a physician with a PhD in Microbiology and Immunology.  "No other cold prevention product on the market has results comparable to what we have been able to demonstrate with Swype.  By using Swype to kill virus on the skin at the entrance to your nose, you are significantly reducing the chance you catch a cold or flu.  In addition, about 85% of participants reported they would continue to use the product and recommend it to friends, indicating Swype is easy to use and effective."

Swype Cold & Flu Shield is available on the Swype website (www.SwypeForHealth.com).  A tube that lasts approximately 2 months costs $12.99.  Nuance Health is currently offering 20% off orders by using code "CLIN20".  

For more information about Swype, visit www.SwypeForHealth.com.

About Nuance Health

Nuance Health was started by a physician and his wife. Together, they use their understanding of science to develop safe and effective products that help people maintain good health.  

CONTACT INFORMATION:
Jim McDonald
877-367-7997 x704
Jim@NuanceHealth.com


'/>"/>
SOURCE Nuance Health
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nuance Health Introduces Swype, an Innovative New Product Designed to Enhance Defense Against Colds and Flu
2. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
3. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
4. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
5. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
6. Robbins & Myers Announces Regular Quarterly Cash Dividend
7. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
8. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
9. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
10. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
11. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Research and Markets has announced the addition of the "Hemophilia ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... questions: What are the key drugs marketed ... Global Hemophilia market? What are the unit prices and ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... Feb. 23, 2017  Directors from Pharma To Market Pty Ltd ... joined forces, resulting in the founding of Pharma To Market Pte ... To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... the Singapore based entity. Joelle brings with ...
Breaking Medicine Technology:
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Elisa Guajardo Carothers is not your typical ... to studying to become a nun. Now, she writes about God, when she isn’t swimming ... Know BC and AD, Here is BS! (Before Satan),” she offers a comedic look at ...
(Date:2/27/2017)... N. Y. (PRWEB) , ... February 27, 2017 , ... ... ( ILADS ) has disclosed that despite scientific studies, the Center for Disease Control ... chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into a ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is an extension of ... to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite ... globally recognised standard that sets out requirements for the technical competence of testing ...
(Date:2/26/2017)... (PRWEB) , ... February 26, ... ... sets a new technology standard in staffing, scheduling, and reporting for healthcare ... and predict activity throughout the entire staffing process. StaffBridge technology improves staffing ...
Breaking Medicine News(10 mins):